Bajaj Finserv Healthcare Fund - Direct Plan - Growth

Regular

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.
Direct

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.

Category : Sectoral/Thematic

Fund House :

NAV

This number shows latest NAV (Net Asset Value) and change in the NAV from previous day. NAV is nothing but the unit price for the fund. You will be allocated number of units based on this price. NAV is declared once each day generally at the end of the day. Once you invest in mutual funds, your money is further invested in stocks and bonds by mutual fund managers. Mutual Fund NAV is the per unit latest value of all such stocks/bonds held in the portfolio

: ₹ 10.075 0.32%
(as on 28th November, 2025)

Crisil Rating

Not Rated

Rank not available for the fund

Fund Size

: ₹ 335.88 Cr

(0.06% of Investment in Category)

Expense Ratio

: 0.72%

(0.89% Category average)

Risk-O-Meter

Very High Risk

Sectoral/Thematic :Sectoral/Thematic : The fund has 92.33% investment in domestic equities of which 30.26% is in Large Cap stocks, 23.82% is in Mid Cap stocks, 7.63% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

1M
3M
6M
1Y
2Y
5Y
ALL

This Scheme

VS

Benchmark
BSE Healthcare TRI

0%

0%

0%

0%

0%

0%

0%
NA
0.09%

5.14%

6.55%

6.1%

19.21%

21.34%

14.14%

NA
Gold

Compare with

Date : -
NAV : -

1M
3M
6M
9M
1Y
2Y
3Y
5Y
ALL

Date : -
Investment : -
Value on selected date : -

Returns Calculator
SIP Calculator
VIP (Value Avg)

Amount

₹

Investment Date
Sell Date

Investment Value

-
Sell Value

-
Profit/Loss

-
Annualised Returns

-

Date : -
Investment : -
Value on selected date : -

Returns (NAV as on 28th November, 2025)

Period Invested for	₹10000 Invested on	Latest Value	Absolute Returns	Annualised Returns	Category Avg	Rank within Category
1 Week	21-Nov-25	10114.40	1.14%	-	0.65%	39/227
1 Month	28-Oct-25	10101.30	1.01%	-	0.09%	68/230
3 Month	28-Aug-25	10324.90	3.25%	-	5.14%	164/226
6 Month	28-May-25	10658.00	6.58%	-	6.55%	99/215
YTD	01-Jan-25	9974.30	-0.26%	-	5.70%	152/201
Since Inception	27-Dec-24	10075.00	0.75%	0.81%	14.14%	185/201

Returns Calculator Detailed Returns Analysis

SIP Returns (NAV as on 28th November, 2025)

Period Invested for	₹1000 SIP Started on	Investments	Latest Value	Absolute Returns	Annualised Returns
No Data Found

SIP Calculator Detailed Returns Analysis

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Oct,2025)

Equity Holding : 92.33% | F&O Holdings : 3.48%| Foreign Equity Holdings : 0.00%| Total : 95.81%

No of Stocks : 41 (Category Avg - 44.44) | Large Cap Investments : 30.26%| Mid Cap Investments : 23.82% | Small Cap Investments : 7.63% | Other : 34.1%

Top 10 Stocks in Portfolio

How to read this table?

Stock Invested in	Sector	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty
Divis Laboratories Ltd.	Pharmaceuticals	296	8.81%	1.06%	9.27% (Apr 2025)	0% (Nov 2024)	43.94 k	0.00
Sun Pharmaceutical Industries Ltd.	Pharmaceuticals	257.4	7.66%	0.13%	8.83% (Apr 2025)	0% (Nov 2024)	1.52 L	0.00
Apollo Hospitals Enterprises Ltd.	Hospital	210.1	6.26%	-0.03%	6.29% (Aug 2025)	0% (Nov 2024)	27.36 k	0.00
Cipla Ltd.	Pharmaceuticals	168	5.00%	-0.45%	8.33% (Apr 2025)	0% (Nov 2024)	1.12 L	-4.90 k
Neuland Laboratories Ltd.	Pharmaceuticals	137.4	4.09%	0.31%	4.09% (Oct 2025)	0% (Nov 2024)	8.34 k	0.00
Biocon Ltd.	Pharmaceuticals	126.4	3.76%	0.17%	4.24% (Jan 2025)	0% (Nov 2024)	3.40 L	0.00
Fortis Healthcare Ltd.	Hospital	123	3.66%	-0.17%	3.83% (Sep 2025)	0% (Nov 2024)	1.20 L	-7.23 k
Aurobindo Pharma Ltd. : Futures Near	Pharmaceuticals	116.8	3.48%	0.04%	3.48% (Oct 2025)	0% (Nov 2024)	1.02 L	0.00
Piramal Pharma Ltd.	Pharmaceuticals	108.9	3.24%	0.01%	3.98% (Jan 2025)	0% (Nov 2024)	5.45 L	0.00
Emcure Pharmaceuticals Ltd.	Pharmaceuticals	108.2	3.22%	-0.04%	3.45% (Aug 2025)	0% (Nov 2024)	82.00 k	0.00

- indicates change in weight in the portfolio. # indicates a new entry.

Detailed Portfolio Analysis

Name	Type of Instrument	Weight (%)
TREPS	TREPS	4.38%
MF Units	MF Units	1.49%
Net Receivables	Net Receivables	-1.68%

Detailed Portfolio Analysis

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)

No data available. Ratios are only available for the funds which are 3 years old.

Alternative Funds (Category Peers)

Scheme Name	Crisil Rank	Asset Size (Cr)	1M	3M	6M	1Y	3Y
Nippon India Taiwan Equity Fund - Direct Plan - Growth	NA	421.51	3.79	18.32	55.07	60.97	38.91
Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth	NA	273.51	-0.19	4.85	16.78	30.47	16.10
Quant BFSI Fund - Direct Plan - Growth	NA	680.73	1.61	11.63	17.16	24.48	0.00
Franklin Asian Equity Fund - Direct - Growth	NA	297.12	-1.18	9.77	18.80	23.94	14.32
ITI Banking and Financial Services Fund - Direct Plan - Growth	NA	333.18	3.00	12.88	10.68	21.39	15.81
HDFC Transportation and Logistics Fund - Direct Plan - Growth	NA	1733.63	-0.68	5.86	20.71	21.13	0.00
DSP Banking & Financial Services Fund - Direct Plan - Growth	NA	1518.73	1.46	11.20	8.14	20.90	0.00
Nippon India Japan Equity Fund - Direct Plan - Growth	NA	292.35	-0.29	3.05	11.22	20.27	16.58
Mirae Asset Banking and Financial Services Fund - Direct Plan - Growth	NA	2130.33	3.02	11.81	10.80	19.82	19.17
SBI Banking & Financial Services Fund - Direct Plan - Growth	NA	9273.44	2.55	10.87	11.92	19.71	21.02

Detailed Comparison

More Funds from

Out of 19 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 1 is/are ranked 3 * , and 16 schemes are not ranked. See more about AMC

Scheme Name	Crisil Rank	Asset Size (Cr)	1M	3M	6M	1Y
Bajaj Finserv Money Market Fund - Direct Plan - Growth	5	6101.32	0.53	1.55	3.30	7.73
Bajaj Finserv Flexi Cap Fund - Direct Plan - Growth	NA	6034.03	0.77	6.20	8.47	9.49
Bajaj Finserv Liquid Fund - Direct Plan - Growth	5	5996.06	0.50	1.46	2.98	6.68
Bajaj Finserv Large and Mid Cap Fund - Direct Plan - Growth	NA	2245.16	2.16	6.53	6.26	7.56
Bajaj Finserv Large Cap Fund - Direct Plan - Growth	NA	1666.14	1.84	8.06	7.41	8.45
Bajaj Finserv Small Cap Fund - Direct Plan - Growth	NA	1512.36	-1.71	3.37	0.00	0.00
Bajaj Finserv Balanced Advantage - Direct Plan - Growth	NA	1325.24	1.89	7.37	6.57	9.97
Bajaj Finserv Multi Asset Allocation Fund - Direct Plan - Growth	NA	1283.50	2.84	11.41	12.08	16.06
Bajaj Finserv Arbitrage Fund - Direct Plan - Growth	3	1256.94	0.57	1.54	3.13	6.80
Bajaj Finserv Multi Cap Fund - Direct Plan - Growth	NA	1022.75	1.19	6.01	4.59	0.00